VAMP1

VAMP1 (Vesicle-Associated Membrane Protein 1), also known as synaptobrevin-1, is a protein that in humans is encoded by the VAMP1 gene. It is a member of the SNARE protein family, which is involved in the docking and fusion of vesicles with their target membranes. This process is critical for the efficient transport of molecules within cells, and is particularly important in the context of neurotransmitter release at synaptic junctions.
Function
VAMP1 is primarily found in the nervous system, where it plays a key role in the exocytosis of synaptic vesicles, thereby facilitating neurotransmitter release and propagation of nerve impulses across synapses. It forms a complex with syntaxin and SNAP-25 to create a core SNARE complex, which is essential for the fusion of vesicles with the target membrane.
Clinical Significance
Alterations in the expression or function of VAMP1 have been implicated in various neurological disorders. For example, antibodies against VAMP1 have been associated with Stiff person syndrome, a rare neurological disorder characterized by stiffness and spasms of muscles. Additionally, mutations in the VAMP1 gene may contribute to the development of certain neurodegenerative diseases, although more research is needed to fully understand these connections.
Genetic Information
The VAMP1 gene is located on the short (p) arm of chromosome 12 (12p13.31) in humans. It consists of several exons and introns that encode the protein VAMP1. The gene undergoes transcription and translation processes to produce the VAMP1 protein, which then participates in vesicular transport mechanisms within cells.
Research
Ongoing research is focused on elucidating the precise mechanisms by which VAMP1 and other SNARE proteins mediate vesicular transport and neurotransmitter release. Understanding these processes at a molecular level may provide insights into the pathogenesis of neurological disorders and lead to the development of novel therapeutic strategies.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
